A detailed history of Neuberger Berman Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 2,222,227 shares of ABBV stock, worth $393 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
2,222,227
Previous 1,953,375 13.76%
Holding current value
$393 Million
Previous $335 Million 30.98%
% of portfolio
0.36%
Previous 0.28%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $44 Million - $53.6 Million
268,852 Added 13.76%
2,222,227 $439 Million
Q2 2024

Nov 14, 2024

BUY
$154.79 - $180.76 $15.4 Million - $18 Million
99,497 Added 5.37%
1,953,375 $335 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $15.4 Million - $18 Million
99,497 Added 5.37%
1,953,375 $335 Million
Q1 2024

Nov 14, 2024

BUY
$159.82 - $182.1 $43.5 Million - $49.5 Million
271,927 Added 17.19%
1,853,878 $338 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $296 Million - $338 Million
1,853,878 New
1,853,878 $338 Million
Q4 2023

Nov 14, 2024

SELL
$137.6 - $154.97 $51.1 Million - $57.6 Million
-371,424 Reduced 19.01%
1,581,951 $245 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $1.9 Million - $2.14 Million
13,791 Added 0.88%
1,581,951 $245 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $3.71 Million - $4.3 Million
-27,778 Reduced 1.74%
1,568,160 $234 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $22.5 Million - $28 Million
-169,599 Reduced 9.61%
1,595,938 $215 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $27.8 Million - $32 Million
192,280 Added 12.22%
1,765,537 $281 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $74.5 Million - $89.4 Million
538,677 Added 52.07%
1,573,257 $254 Million
Q3 2022

Nov 15, 2022

SELL
$134.21 - $153.93 $20.9 Million - $24 Million
-156,026 Reduced 13.1%
1,034,580 $139 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $7.56 Million - $9.61 Million
54,935 Added 4.84%
1,190,606 $183 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $1.83 Million - $2.26 Million
13,831 Added 1.23%
1,135,671 $179 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $16 Million - $20.2 Million
148,914 Added 15.31%
1,121,840 $146 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $56.7 Million - $64.3 Million
-532,681 Reduced 35.38%
972,926 $101 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $47.3 Million - $52.7 Million
449,737 Added 42.59%
1,505,607 $166 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $43.1 Million - $47.4 Million
420,875 Added 66.28%
1,055,870 $114 Million
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $18.1 Million - $24.5 Million
-225,282 Reduced 26.19%
634,995 $67.8 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $5.46 Million - $6.41 Million
-63,605 Reduced 6.88%
860,277 $75.4 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $28 Million - $37.5 Million
382,265 Added 70.58%
923,882 $90.6 Million
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $5.03 Million - $7.62 Million
77,925 Added 16.81%
541,617 $41.3 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $666,409 - $833,819
9,239 Added 2.03%
463,692 $41.1 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $1.59 Million - $1.92 Million
-25,325 Reduced 5.28%
454,453 $34.4 Million
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $164,907 - $210,789
-2,510 Reduced 0.52%
479,778 $34.9 Million
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $4.33 Million - $5.09 Million
-56,083 Reduced 10.42%
482,288 $38.9 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $3 Million - $3.7 Million
-38,542 Reduced 6.68%
538,371 $49.6 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $1.86 Million - $2.07 Million
-20,933 Reduced 3.5%
576,913 $54.6 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $388,029 - $459,126
-4,322 Reduced 0.72%
597,846 $55.5 Million
Q1 2018

May 08, 2018

SELL
$92.01 - $123.21 $12.7 Million - $17.1 Million
-138,433 Reduced 18.69%
602,168 $57.1 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $11.5 Million - $12.6 Million
128,013 Added 20.9%
740,601 $71.7 Million
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $42.8 Million - $54.7 Million
612,588
612,588 $54.4 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.